Amphastar Pharmaceuticals (AMPH) Return on Capital Employed (2014 - 2026)

Amphastar Pharmaceuticals' Return on Capital Employed history runs 13 years deep, the most recent figure standing at 0.16% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 1372.0% year-over-year to 0.16%; the TTM figure through Mar 2026 stood at 0.16% (down 1372.0% YoY), while the FY2025 annual figure was 1.8%, down 1318.0% from the prior year.
• Return on Capital Employed was 0.16% for Q1 2026 at Amphastar Pharmaceuticals, down from 1.74% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 18.29% in Q1 2023 to a low of 0.16% in Q1 2026.
• Historically, Return on Capital Employed has averaged 13.41% across 5 years, with a median of 15.07% in 2022.
• The sharpest annual moves came in 2022 and 2026: Return on Capital Employed jumped 1132 bps in 2022, then sank 1372 bps in 2026.
• A 5-year view of Return on Capital Employed shows it stood at 16.81% in 2022, then fell by 10 bps to 15.11% in 2023, then decreased by 2 bps to 14.8% in 2024, then plunged by 88 bps to 1.74% in 2025, then tumbled by 91 bps to 0.16% in 2026.
• The last three Return on Capital Employed figures came in at 0.16% (Q1 2026), 1.74% (Q4 2025), and 10.44% (Q3 2025), per Business Quant data.